Since the British-Swedish pharmaceutical giant AstraZeneca’s admission that its COVID-19 vaccine can cause a rare side effect of blood clotting has come to light, concerns have arisen about its safety among those who took the jab in India. The vaccine was marketed as Covishield in the South Asian country and was manufactured by the Pune-based Serum Institute of India (SII).
#covisheild #covid19news #covidvaccine #news18
